Share
Market Research Report

U.S. OPHTHALMIC COMPOUNDING PHARMACIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By DrugMitomycin · Amphotericin · Fluconazole · Voriconazole · Tropicamide · Atropine Sulfate · Albumin 5% · Cyclosporine 0.5-2% · Moxifloxacin · Gentamicin · Vancomycin · Amikacin · Tobramycin · Tetracycline · Metronidazole · Acetylcysteine · Bevacizumab · Tacrolimus · Retinoic Acid · Carosine · Latanoprost · Dorzolamide · Brimonidine · Timolol · and Others
  • By FormulationEye Drops · Ointments · Injections · and Others
  • By Therapeutic ApplicationDry Eyes · Glaucoma · Cataracts · Conjunctivitis · Age-related Macular Degeneration · Uveitis (Eye Inflammation) · and Others
  • By Pharmacy Type503A and 503B
  • Published In06 Mar 2026
  • Report CodeCMI4921
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

Market Segmentation

  • By Drug

    • Mitomycin
    • Amphotericin
    • Fluconazole
    • Voriconazole
    • Tropicamide
    • Atropine Sulfate
    • Albumin 5%
    • Cyclosporine 0.5-2%
    • Moxifloxacin
    • Gentamicin
    • Vancomycin
    • Amikacin
    • Tobramycin
    • Tetracycline
    • Metronidazole
    • Acetylcysteine
    • Bevacizumab
    • Tacrolimus
    • Retinoic Acid
    • Carosine
    • Latanoprost
    • Dorzolamide
    • Brimonidine
    • Timolol
    • Others
  • By Formulation

    • Eye Drops
    • Ointments
    • Injections
    • Others
  • By Therapeutic Application

    • Dry Eyes
    • Glaucoma
    • Cataracts
    • Conjunctivitis
    • Age-related Macular Degeneration
    • Uveitis (Eye Inflammation)
    • Others
  • By Pharmacy Type

    • 503A
    • 503B